Not available
Quote | BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX)
Last: | $7.85 |
---|---|
Change Percent: | -1.85% |
Open: | $7.69 |
Close: | $7.85 |
High: | $7.87 |
Low: | $7.52 |
Volume: | 2,359,513 |
Last Trade Date Time: | 07/26/2024 03:00:00 am |
News | BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX)
RESEARCH TRIANGLE PARK, N.C., July 22, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its second quarter 2024 financial results on Monday, August 5, 2024. BioCryst management will host a conference call and webcast ...
RESEARCH TRIANGLE PARK, N.C., July 09, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the General Directorate of Medicines, Supplies and Drugs (DIGEMID) in Peru has granted approval for oral, once-daily ORLADEYO ® (berotralstat) for t...
Message Board Posts | BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $BCRX News Article - BioCryst Pharmaceuticals (BCRX) Q1 2023 Earnings Call Transcript | whytestocks | investorshangout | 05/03/2023 6:15:53 PM |
whytestocks: $BCRX News Article - BioCryst Presents New Long-term and Real-world Data Demonstrating | whytestocks | investorshangout | 02/24/2023 1:35:47 PM |
Huge buys in AH | ttubular | investorshub | 01/25/2023 11:01:34 PM |
Why is this symbol now taking a digger | VivaLasVegas | investorshub | 12/14/2022 11:39:49 PM |
whytestocks: $BCRX News Article - FDA Grants Orphan Drug Designation for BioCryst's ALK-2 Inhibitor, | whytestocks | investorshangout | 08/31/2022 2:10:56 PM |
News, Short Squeeze, Breakout and More Instantly...
BioCryst Pharmaceuticals Inc. Company Name:
BCRX Stock Symbol:
NASDAQ Market:
BioCryst Pharmaceuticals Inc. Website:
RESEARCH TRIANGLE PARK, N.C., July 22, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its second quarter 2024 financial results on Monday, August 5, 2024. BioCryst management will host a conference call and webcast ...
RESEARCH TRIANGLE PARK, N.C., July 09, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the General Directorate of Medicines, Supplies and Drugs (DIGEMID) in Peru has granted approval for oral, once-daily ORLADEYO ® (berotralstat) for t...
2024-06-27 04:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...